High-resolution spatial transcriptomics through light patterning
通过光图案化的高分辨率空间转录组学
基本信息
- 批准号:10341212
- 负责人:
- 金额:$ 17.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-01 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdoptionAntibodiesArchitectureB-Cell LymphomasBackBar CodesBiological ProcessCell NucleusCell-Matrix JunctionCellsCensusesCharacteristicsChemistryClinicalComplementary DNAComputing MethodologiesCultured CellsDNADiseaseDissociationDrug resistanceGene ExpressionGene Expression ProfileGene Expression ProfilingGenesHeartHeterogeneityHodgkin DiseaseImmune EvasionImmunohistochemistryImmunomodulatorsIn Situ HybridizationIndividualKnowledgeLabelLengthLigationLightLightingLiquid substanceLocationMapsMature B-LymphocyteMeasuresMethodsMolecularNuclearOpticsPatternPharmaceutical PreparationsPhenotypePositioning AttributeProceduresProteinsProtocols documentationRNAReactionReproducibilityResearch PersonnelResearch Project GrantsResistanceResolutionSamplingSeriesShapesSplit-Pool Ligation Transcriptome sequencingTechniquesTechnologyTimeTissuesTranscriptTumor TissueWorkanticancer researchbasecancer diagnosiscell typecombinatorialcostdetection sensitivityexperimental studyflexibilitygenome-wideimmunomodulatory therapiesimprovedindexinginnovationinstrumentinterestnew therapeutic targetpatient stratificationpredicting responsepreservationprototyperesponsesingle-cell RNA sequencingspatial relationshipsuccesstooltranscriptometranscriptomicstreatment responsetumortumor heterogeneitytumor microenvironment
项目摘要
PROJECT SUMMARY
The cellular composition of a tumor as well as the spatial arrangement of cells within the tumor are major
determinants of the response to therapy and the emergence of resistance. To improve our understanding of
tumor heterogeneity, accelerate the discovery of new drug targets or enable better patient stratification it is thus
necessary to develop tools that can resolve molecularly defined cell types within a tumor and capture their spatial
relationships. Driven by progress in single-cell RNA sequencing (scRNA-seq) technologies, a complete census
of molecularly defined cell types within a tumor is now within reach. However, because scRNA-seq requires
dissociated cells and cannot preserve information about the spatial arrangement of cells in their original context,
it gives an incomplete picture of the relationship between gene expression, cell type identity and tumor
architecture. The need for technologies that measure gene expression in single cells while retaining position
information has long been recognized, but existing solutions have insufficient cellular throughput, spatial
resolution, or gene detection sensitivity. We propose to develop Combinatorial Light-Activated Spatial
Sequencing (CLASSeq), a transformative approach to spatial transcriptomics that overcomes these limitations.
CLASSeq uses patterned light illumination to attach DNA barcodes encoding location information to all cells of
interest within a tissue section, with spatial resolution limited only by the wavelength of light. Spatial barcodes
are sequenced together with cellular transcriptomes after dissociating the tissue into individual cells or nuclei,
and tissue-wide gene expression patterns are computationally recreated. Because sequencing is performed after
dissociation, any established scRNA-seq workflow can be used, enabling high sensitivity and cell throughput. To
achieve high throughput and reproducibility, and facilitate wide adoption, we will work toward automating the
labeling workflow by constructing a prototype instrument that integrates fluidics for barcode delivery with
patterned illumination. To validate our approach and demonstrate its utility to cancer research, CLASSeq will be
used to characterize cellular diversity and organization in Hodgkin lymphoma, a mature B-cell lymphoma in which
the tumor microenvironment niche is critical to the tumor's success for host immune evasion and thus governs
the response or lack thereof to clinical immune modulatory therapies.
项目摘要
肿瘤的细胞组成以及肿瘤内细胞的空间排列是主要的
治疗反应的决定因素和耐药性的出现。为了提高我们对
肿瘤异质性,加速发现新的药物靶点或使更好的患者分层,因此,
有必要开发能够解析肿瘤内分子定义的细胞类型并捕获其空间分布的工具
关系。在单细胞RNA测序(scRNA-seq)技术进步的推动下,
在肿瘤内的分子定义的细胞类型现在是触手可及的。然而,由于scRNA-seq需要
分离的细胞并且不能保存关于细胞在其原始环境中的空间排列的信息,
它对基因表达、细胞类型和肿瘤之间的关系给出了不完整的描述。
架构需要在单细胞中测量基因表达的技术,同时保留位置
信息已经被长期认识到,但是现有的解决方案具有不足的蜂窝吞吐量、空间
分辨率或基因检测灵敏度。我们建议开发组合式光激活空间
测序(CLASSeq),一种克服这些限制的空间转录组学的变革性方法。
CLASSeq使用图案化的光照射将编码位置信息的DNA条形码附着到所有细胞,
组织切片内的感兴趣区域,空间分辨率仅受光波长的限制。空间条码
在将组织解离成单个细胞或细胞核后与细胞转录组一起测序,
并通过计算重建组织范围的基因表达模式。因为测序是在
在解离过程中,可以使用任何已建立的scRNA-seq工作流程,从而实现高灵敏度和细胞通量。到
实现高通量和再现性,并促进广泛采用,我们将致力于自动化,
通过构建原型仪器来实现标记工作流程,
图案照明。为了验证我们的方法并证明其对癌症研究的实用性,CLASSeq将在
用于表征霍奇金淋巴瘤的细胞多样性和组织,霍奇金淋巴瘤是一种成熟B细胞淋巴瘤,
肿瘤微环境生态位对于肿瘤成功逃避宿主免疫至关重要,
对临床免疫调节疗法的应答或缺乏应答。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A comprehensive analysis of gene expression changes in a high replicate and open-source dataset of differentiating hiPSC-derived cardiomyocytes.
- DOI:10.1038/s41598-021-94732-1
- 发表时间:2021-08-04
- 期刊:
- 影响因子:4.6
- 作者:Grancharova T;Gerbin KA;Rosenberg AB;Roco CM;Arakaki JE;DeLizo CM;Dinh SQ;Donovan-Maiye RM;Hirano M;Nelson AM;Tang J;Theriot JA;Yan C;Menon V;Palecek SP;Seelig G;Gunawardane RN
- 通讯作者:Gunawardane RN
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Georg Seelig其他文献
Georg Seelig的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Georg Seelig', 18)}}的其他基金
Engineering cell type-specific splicing regulation
工程细胞类型特异性剪接调控
- 批准号:
10633765 - 财政年份:2023
- 资助金额:
$ 17.81万 - 项目类别:
Joint receptor and protein expression immunophenotyping through split-pool barcoding
通过分池条形码进行联合受体和蛋白质表达免疫表型
- 批准号:
10625987 - 财政年份:2021
- 资助金额:
$ 17.81万 - 项目类别:
Joint receptor and protein expression immunophenotyping through split-pool barcoding
通过分池条形码进行联合受体和蛋白质表达免疫表型
- 批准号:
10375354 - 财政年份:2021
- 资助金额:
$ 17.81万 - 项目类别:
High-resolution spatial transcriptomics through light patterning
通过光图案化的高分辨率空间转录组学
- 批准号:
9886581 - 财政年份:2020
- 资助金额:
$ 17.81万 - 项目类别:
A massively parallel reporter assay for measuring chromatin effects on alternative splicing
用于测量染色质对选择性剪接的影响的大规模并行报告分析
- 批准号:
10161803 - 财政年份:2020
- 资助金额:
$ 17.81万 - 项目类别:
A massively parallel reporter assay for measuring chromatin effects on alternative splicing
用于测量染色质对选择性剪接的影响的大规模并行报告分析
- 批准号:
9977420 - 财政年份:2020
- 资助金额:
$ 17.81万 - 项目类别:
High-resolution spatial transcriptomics through light patterning
通过光图案化进行高分辨率空间转录组学
- 批准号:
10112854 - 财政年份:2020
- 资助金额:
$ 17.81万 - 项目类别:
A predictive model of mRNA stability and translation for variant interpretation and mRNA therapeutics
用于变异解释和 mRNA 治疗的 mRNA 稳定性和翻译的预测模型
- 批准号:
9894822 - 财政年份:2018
- 资助金额:
$ 17.81万 - 项目类别:
Predictive Modeling of Alternative Splicing and Polyadenylation from Millions of Random Sequences
数百万随机序列的选择性剪接和聚腺苷酸化的预测模型
- 批准号:
9306648 - 财政年份:2017
- 资助金额:
$ 17.81万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 17.81万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 17.81万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 17.81万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 17.81万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 17.81万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 17.81万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 17.81万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 17.81万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 17.81万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 17.81万 - 项目类别: